Bohannon Julia K, Luan Liming, Hernandez Antonio, Afzal Aqeela, Guo Yin, Patil Naeem K, Fensterheim Benjamin, Sherwood Edward R
Departments of *Anesthesiology, Neurosurgery, and Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Departments of *Anesthesiology, Neurosurgery, and Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
J Leukoc Biol. 2016 Apr;99(4):629-40. doi: 10.1189/jlb.4A0815-362R. Epub 2015 Nov 4.
Infection is the leading cause of death in severely burned patients that survive the acute phase of injury. Neutrophils are the first line of defense against infections, but hospitalized burn patients frequently cannot mount an appropriate innate response to infection. Thus, immune therapeutic approaches aimed at improving neutrophil functions after burn injury may be beneficial. Prophylactic treatment with the TLR4 agonist monophosphoryl lipid A is known to augment resistance to infection by enhancing neutrophil recruitment and facilitating bacterial clearance. This study aimed to define mechanisms by which monophosphoryl lipid A treatment improves bacterial clearance and survival in a model of burn-wound sepsis. Burn-injured mice were treated with monophosphoryl lipid A or vehicle, and neutrophil mobilization was evaluated in the presence or absence of Pseudomonas aeruginosa infection. Monophosphoryl lipid A treatment induced significant mobilization of neutrophils from the bone marrow into the blood and sites of infection. Neutrophil mobilization was associated with decreased bone marrow neutrophil CXCR4 expression and increased plasma G-CSF concentrations. Neutralization of G-CSF before monophosphoryl lipid A administration blocked monophosphoryl lipid A-induced expansion of bone marrow myeloid progenitors and mobilization of neutrophils into the blood and their recruitment to the site of infection. G-CSF neutralization ablated the enhanced bacterial clearance and survival benefit endowed by monophosphoryl lipid A in burn-wound-infected mice. Our findings provide convincing evidence that monophosphoryl lipid A-induced G-CSF facilitates early expansion, mobilization, and recruitment of neutrophils to the site of infection after burn injury, allowing for a robust immune response to infection.
感染是严重烧伤患者在度过急性损伤期后死亡的主要原因。中性粒细胞是抵御感染的第一道防线,但住院的烧伤患者往往无法对感染产生适当的先天性免疫反应。因此,旨在改善烧伤后中性粒细胞功能的免疫治疗方法可能有益。已知用TLR4激动剂单磷酰脂质A进行预防性治疗可通过增强中性粒细胞募集和促进细菌清除来增强抗感染能力。本研究旨在确定单磷酰脂质A治疗在烧伤创面脓毒症模型中改善细菌清除和提高生存率的机制。对烧伤小鼠用单磷酰脂质A或赋形剂进行治疗,并在有或无铜绿假单胞菌感染的情况下评估中性粒细胞的动员情况。单磷酰脂质A治疗可诱导中性粒细胞从骨髓大量动员至血液和感染部位。中性粒细胞的动员与骨髓中性粒细胞CXCR4表达降低和血浆G-CSF浓度升高有关。在给予单磷酰脂质A之前中和G-CSF可阻断单磷酰脂质A诱导的骨髓髓系祖细胞扩增以及中性粒细胞向血液中的动员及其向感染部位的募集。G-CSF中和消除了单磷酰脂质A赋予烧伤创面感染小鼠的增强的细菌清除和生存益处。我们的研究结果提供了令人信服的证据,即单磷酰脂质A诱导的G-CSF促进烧伤后中性粒细胞向感染部位的早期扩增、动员和募集,从而对感染产生强大的免疫反应。